Elimination of Rubella and Congenital Rubella Syndrome in the Americas
Elimination of Rubella and Congenital Rubella Syndrome in the Americas
复制标题
DOI：
10.1093/infdis/jir472
复制
发表时间：
2011-09-01
影响因子：
6.4
通讯作者：
Andrus, Jon Kim
中科院分区：
文献类型：
--
作者：
Castillo-Solorzano, Carlos;Marsigli, Christina;Andrus, Jon Kim
2003年，泛美卫生组织（PAHO）通过决议，要求到2010年在美洲消除风疹和先天性风疹综合征（CRS）。为实现这一目标，泛美卫生组织提出了消除风疹和先天性风疹综合征（CRS）的战略，包括将含有风疹的疫苗纳入常规疫苗接种计划并提高免疫覆盖率，通过对青少年和成人进行大规模疫苗接种来阻断风疹传播，并加强对风疹和CRS的监测。风疹消除策略与成功的麻疹消除策略一致。截至2009年底，各国已对儿童常规接种风疹疫苗，估计有4.5亿人在补充免疫活动中接种了麻疹和风疹疫苗，风疹传播已被阻断。本文介绍了该地区如何消除风疹和 CRS。
In 2003, the Pan American Health Organization (PAHO) adopted a resolution calling for rubella and congenital rubella syndrome (CRS) elimination in the Americas by the year 2010. To accomplish this goal, PAHO advanced a rubella and CRS elimination strategy including introduction of rubella-containing vaccines into routine vaccination programs accompanied by high immunization coverage, interruption of rubella transmission through mass vaccination of adolescents and adults, and strengthened surveillance for rubella and CRS. The rubella elimination strategies were aligned with the successful measles elimination strategies. By the end of 2009, all countries routinely vaccinated children against rubella, an estimated 450 million people had been vaccinated against measles and rubella in supplementary immunization activities, and rubella transmission had been interrupted. This article describes how the region eliminated rubella and CRS.